| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |